Figure 3. Unified Parkinson’s Disease Rating Scale (UPDRS) scores across four week study revealed no significant difference between placebo and olanzapine groups among study completers.

Current effect: F(2, 24)=0.50826, p=0.60787. Effective hypothesis decomposition. Vertical bars denote 0.95 confidence intervals. Olanzapine-blue; placebo-red.